Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration

Tuesday, October 14, 2025 1 min read

Key Takeaway: Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration

Full Press Release Details

Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration.